IP Library › Granted Patent US 10,596,194
Granted Patent B2
US 10,596,194 · App. 15/563,712 · Granted Mar 24, 2020

Powder compositions for generating cross-linked protein foams and methods of using thereof

Inventor: Ishay Attar (Hoff Carmel, IL)
Assignee: Biochange Ltd.
A61K35/12A61B17/064A61K9/122A61K47/42A61L27/3604A61L27/3843
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,596,194
App. No.
15/563,712
Granted
Mar 24, 2020
Kind
B2
Abstract

In one embodiment, the present invention provides a composition, wherein the composition is a porous scaffold, wherein the pores of the scaffold are from 2 to 500 microns, the composition comprising: a) a cross-linkable protein selected from the group consisting of collagen and gelatin; b) a cross-linker which induces cross-linking of the cross-linkable protein; and c) a liquid.

Claims (24)

1. A composition, comprising:

a closed-cell foam;

wherein the composition comprises:

a. cross-linkable gelatin;

b. a cross-linker; and

c. a liquid,

wherein the composition is a porous scaffold, having a pore size from 2 to 500 microns,

wherein the cross-linkable gelatin is introduced into the composition as a hygroscopic gelatin powder, having a particle size between 5 to 200 microns,

wherein the cross-linkable gelatin is present in the composition in the range of 0.5 wt % to 25 wt %, and

wherein the cross-linker is present in the composition in the range of 0.0001 wt % to 2 wt %.

2. The composition of claim 1 , wherein the liquid is a physiological buffer.

3. The composition of claim 1 , wherein the composition is formed in situ in a patient at a site where the patient is in need of treatment of a tissue defect.

4. The composition of claim 1 , wherein the composition is formed prior to introducing the composition into a patient at a site where the patient is in need of treatment of a tissue defect.

5. A composition, comprising:

a closed-cell foam;

wherein the composition comprises:

a. cross-linkable gelatin;

b. a transglutaminase which induces cross-linking of the cross-linkable gelatin; and

c. a liquid,

wherein the composition is a porous scaffold, having a pore size from 2 to 500 microns,

wherein the cross-linkable gelatin is introduced into the composition as a hygroscopic gelatin powder, having a particle size between 5 to 200 microns,

wherein the cross-linkable gelatin is present in the composition in the range of 0.5 wt % to 25 wt %, and

wherein the transglutaminase is present in the composition in the range of 0.0001 wt % to 2 wt %.

6. The composition of claim 1 , wherein the composition comprises a solution at a temperature of 4° C. to 37° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2019
From: ATTAR, ISHAY
To: BIOCHANGE LTD.
Reel/Frame 050657/0489 →
Continuity (6)
Provisional Application 62142713 · Apr 3, 2015
Provisional Application 62142715 · Apr 3, 2015
Provisional Application 62142725 · Apr 3, 2015
Provisional Application 62142732 · Apr 3, 2015
Provisional Application 62142738 · Apr 3, 2015
Related Publication 20180256641A1 · Sep 13, 2018